AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 46 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 179,162 | $2,523,000 | 1.80% |
| Baker Brothers Advisors | 10,934,154 | $153,953,000 | 1.30% |
| Ghost Tree Capital, LLC | 400,000 | $5,632,000 | 1.14% |
| Boxer Capital, LLC | 747,500 | $10,525,000 | 1.12% |
| DAFNA Capital Management LLC | 107,928 | $1,520,000 | 0.74% |
| UNIVERSITY OF NOTRE DAME DU LAC | 137,868 | $1,941,000 | 0.36% |
| Eversept Partners, LP | 31,987 | $450,377 | 0.21% |
| DLD Asset Management, LP | 147,900 | $2,078,000 | 0.19% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,535 | $1,064,000 | 0.16% |
| Stonepine Capital Management, LLC | 20,374 | $287,000 | 0.15% |